IE50806B1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
IE50806B1
IE50806B1 IE36/81A IE3681A IE50806B1 IE 50806 B1 IE50806 B1 IE 50806B1 IE 36/81 A IE36/81 A IE 36/81A IE 3681 A IE3681 A IE 3681A IE 50806 B1 IE50806 B1 IE 50806B1
Authority
IE
Ireland
Prior art keywords
tablet
sustained release
amount
pharmaceutical composition
agent
Prior art date
Application number
IE36/81A
Other languages
English (en)
Other versions
IE810036L (en
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of IE810036L publication Critical patent/IE810036L/xx
Publication of IE50806B1 publication Critical patent/IE50806B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IE36/81A 1980-01-11 1981-01-09 Pharmaceutical compositions IE50806B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments

Publications (2)

Publication Number Publication Date
IE810036L IE810036L (en) 1981-07-11
IE50806B1 true IE50806B1 (en) 1986-07-23

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
IE36/81A IE50806B1 (en) 1980-01-11 1981-01-09 Pharmaceutical compositions

Country Status (22)

Country Link
JP (1) JPS56103110A (lv)
AT (1) AT374681B (lv)
AU (1) AU542824B2 (lv)
BE (1) BE886998A (lv)
CA (1) CA1140466A (lv)
CH (1) CH646604A5 (lv)
DE (1) DE3100191A1 (lv)
DK (1) DK6181A (lv)
ES (2) ES498369A0 (lv)
FI (1) FI76927C (lv)
FR (1) FR2473308B1 (lv)
GB (1) GB2067072B (lv)
GR (1) GR73843B (lv)
IE (1) IE50806B1 (lv)
IN (1) IN151913B (lv)
IT (1) IT1221041B (lv)
LU (1) LU83052A1 (lv)
NL (1) NL8100037A (lv)
NO (1) NO156153C (lv)
NZ (1) NZ195933A (lv)
SE (1) SE447450B (lv)
ZA (1) ZA81136B (lv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
DE3486029T2 (de) * 1983-10-14 1993-05-13 Sumitomo Pharma Ifn-praeparat mit verzoegerter abgabe fuer parentale verabreichung.
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
DE3688188T2 (de) * 1985-12-27 1993-10-14 Koken Kk Verfahren zur Herstellung einer Formulierung mit verzögerter Freisetzung.
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
ZA881301B (en) * 1987-02-27 1989-10-25 Lilly Co Eli Sustained release matrix formulations
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
US5855915A (en) 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
NL265428A (lv) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
NO156153C (no) 1987-08-05
ES8205353A1 (es) 1982-06-01
CH646604A5 (fr) 1984-12-14
IE810036L (en) 1981-07-11
NO156153B (no) 1987-04-27
DE3100191C2 (lv) 1988-09-01
IT8147537A0 (it) 1981-01-09
ES8301629A1 (es) 1982-12-16
FR2473308B1 (fr) 1985-07-19
LU83052A1 (fr) 1982-09-10
DK6181A (da) 1981-07-12
NZ195933A (en) 1982-11-23
AU542824B2 (en) 1985-03-14
IN151913B (lv) 1983-09-03
GR73843B (lv) 1984-05-07
AU6597681A (en) 1981-07-16
JPS56103110A (en) 1981-08-18
SE8100104L (sv) 1981-07-12
ES498369A0 (es) 1982-06-01
FI76927B (fi) 1988-09-30
DE3100191A1 (de) 1981-12-10
CA1140466A (en) 1983-02-01
GB2067072A (en) 1981-07-22
FI76927C (fi) 1989-01-10
NO810062L (no) 1981-07-13
FR2473308A1 (fr) 1981-07-17
SE447450B (sv) 1986-11-17
ES509179A0 (es) 1982-12-16
IT1221041B (it) 1990-06-21
FI810056L (fi) 1981-07-12
AT374681B (de) 1984-05-25
GB2067072B (en) 1983-08-10
ZA81136B (en) 1982-01-27
ATA5481A (de) 1983-10-15
NL8100037A (nl) 1981-08-03
BE886998A (fr) 1981-07-08

Similar Documents

Publication Publication Date Title
US4837032A (en) Theophylline sustained release tablet
US5415871A (en) Therapeutic agents
US3965256A (en) Slow release pharmaceutical compositions
IE50806B1 (en) Pharmaceutical compositions
EP0290168B1 (en) Ibuprofen sustained release matrix and process
US4900558A (en) Sustained release ibuprofen formulation including a core of ibuprofen and a microcrystalline cellulose and a covering of acrylic polymer and hydroxylated cellulose derivative
KR100294154B1 (ko) 부프로피온함유서방형정제
US4913906A (en) Novel controlled release dosage form of valproic acid
AU764742B2 (en) Dispersible compositions containing L-DOPA ethyl ester
JPS62106011A (ja) 徐放性錠剤
JPS6354316A (ja) 消炎作用を示す計画的放出型経口投与用医薬製剤
JP2002511849A (ja) 制御された作用物質引渡し量を有する経口的に使用可能な固体の調剤形の製造法
SE454565B (sv) Tablett av controlled release-typ innehallande naproxen eller naproxennatrium
FI96095C (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
KR930008956B1 (ko) 서방형 이부프로펜 제제의 제조방법
US4803080A (en) Sustained-release theophylline formulation
US3524910A (en) Sustained relief analgesic compositions
EP1331972B1 (en) Pharmaceutical compositions
CN114146062B (zh) 一种组合物及其制备方法和用途
US4652442A (en) Process of producing a sustained release preparation containing indomethacin or niomethacin
JPS6087216A (ja) 一定放出性固体投薬形インドメタシン組成物および関節炎その他の炎症性状態の治療法
US4002731A (en) Diagnostic process using sodium tyropanoate
JPS6087217A (ja) 一定放出速度の固体調剤テオフイリン配合物
CN116966157B (zh) 一种茶碱缓释片及其制备方法
JP2638604B2 (ja) 徐放性製剤